当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析

海翔药业

(002099)

  

流通市值:97.43亿  总市值:97.61亿
流通股本:16.16亿   总股本:16.19亿

海翔药业(002099)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.13亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益514445.37万元,未分配利润48930.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产767294.32万元,负债252848.94万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入925,159,120.06486,432,558.841,938,465,657.861,444,477,964.62
营业总成本892,850,523.47466,678,445.961,859,241,448.521,375,713,221.67
其他经营收益
营业利润24,780,775.815,998,250.07-336,143,325.921,715,558.06
利润总额19,295,294.112,599,014.68-336,881,230.273,086,801.44
净利润12,623,205.938,313,435.12-333,887,461.9110,234,312.62
每股收益
其他综合收益--3,828,942.94-
综合收益总额12,623,205.938,313,435.12-330,058,518.9710,234,312.62
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,240,546,292.583,123,540,366.392,890,751,484.572,775,226,104.05
非流动资产:
非流动资产合计4,432,396,876.134,469,401,830.024,565,292,621.84,834,704,756.11
资产总计7,672,943,168.717,592,942,196.417,456,044,106.377,609,930,860.16
流动负债:
流动负债合计2,438,213,104.562,362,252,433.482,228,294,388.642,054,055,029.19
非流动负债:
非流动负债合计90,276,334.8590,545,804.4495,919,194.3695,340,411.11
负债合计2,528,489,439.412,452,798,237.922,324,213,5832,149,395,440.3
所有者权益(或股东权益):
归属于母公司股东权益合计5,153,165,463.635,148,301,694.145,139,071,751.735,466,912,403.08
股东权益合计5,144,453,729.35,140,143,958.495,131,830,523.375,460,535,419.86
负债和股东权益合计7,672,943,168.717,592,942,196.417,456,044,106.377,609,930,860.16
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计864,300,595.69415,838,037.11,547,184,004.11,218,568,767.71
经营活动现金流出小计863,038,479.89440,707,959.991,372,349,133.531,079,072,709.77
经营活动产生的现金流量净额1,262,115.8-24,869,922.89174,834,870.57139,496,057.94
投资活动产生的现金流量:
投资活动现金流入小计411,730,729.06395,206,156.3842,125,374.19127,442,002.71
投资活动现金流出小计354,672,262.0446,905,875.39569,518,780.19232,744,777.1
投资活动产生的现金流量净额57,058,467.02348,300,280.99-527,393,406-105,302,774.39
筹资活动产生的现金流量:
筹资活动现金流入小计1,461,500,000819,100,0002,774,199,4902,179,199,490
筹资活动现金流出小计1,072,270,504535,272,405.832,770,737,620.282,267,819,424.53
筹资活动产生的现金流量净额389,229,496283,827,594.173,461,869.72-88,619,934.53
汇率变动对现金及现金等价物的影响3,156,614.348,909,457.0635,694,131.3613,615,220.99
现金及现金等价物净增加额450,706,693.16616,167,409.33-313,402,534.35-40,811,429.99
期末现金及现金等价物余额1,386,835,010.581,552,295,726.75936,128,317.421,208,719,421.78
补充资料:
现金及现金等价物的净增加额450,706,693.16--313,402,534.35-
TOP↑